DOCSLIB.ORG

An Investigation of Potato Alkaloid Levels in The

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
An Investigation of Potato Alkaloid Levels in The AN INVESTIGATION OF POTATO ALKALOID LEVELS IN THE NORMAL POPULATION AND THEIR RELATIONSHIP TO FOETAL NEURAL TUBE DEFECTS Submitted in fulfilment of the requirements for the degree: Doctor of Philosophy of the University of Surrey by: MICHAEL HUGH HARVEY October 1988 ProQuest Number: 10798521 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 10798521 Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 CONTENTS Page SECTION 1 INTRODUCTION 1.1 Introduction 1 1.2 Chemistry of the Solanum Alkaloids 3 1.3 Biochemistry of the Solanum Alkaloids 10 1.4 Distribution of Glycoalkaloids Within the Potato 14 1.5 Factors Affecting the Formation of Glycoalkaloids 17 1.5.1 Light 17 1.5.2 Temperature and Storage 18 1.5.3 Mechanical Injury 20 1.5.4 Climatic Conditions 21 1.5.5 Cooking and Potato Processing 21 1.5.6 Genetic Control 23 1.5.7 Control of Tuber Glycoalkaloid Content 25 1.6 Physiological Functions of Potato Alkaloids ' , 28 1.7 Analysis of Potato Glycoalkaloids 30 1.7.1 Extraction of Glycoalkaloids from the Potato 30 1.7.2 Colorimetric Quantification 32 1.7.3 Thin-Layer Chromatography 33 1.7.4 Gas Chromatography 34 1.7.5 High Performance Liquid Chromatography 35 1.7.6 Immunoassay Methods 38 1.7.7 Other Methods of Glycoalkaloid Analysis 40 1.8 Pharmacology and Toxicology of Potato 41 Glycoalkaloids 1.8.1 Glycoalkaloid Poisoning in Man and Domestic 41 Anim als 1.8.2 Pharmacology of Potato Glycoalkaloids 44 1.8.3 Pharmacokinetics of Potato Glycoalkaloids 47 1.8.4 Toxicity of Glycoalkaloids in Experimental 49 Anim als 1.8.5 Teratogenic Effects of Potato Glycoalkaloids 52 1.8.6 Aims of the Present Study 52 Page SECTION 2 RADIOIMMUNOASSAY OF POTATO ALKALOIDS 2.1 Introduction 54 2.2 Materials and Methods 64 2.2.1 M aterials 64 2.2.1.1 Assay Buffer 64 2.2.1.2 Immunogen 64 2.2.1.3 Antiserum 64 2.2.1.4 Label 65 2.2.1.3 Standard 65 2.2.1.6 Alkaloid-Free Serum/Urine/Saliva 66 2.2.1.7 Dextran-Coated Charcoal 66 2.2.1.8 Scintillation Vials 66 2.2.1.9 Scintillation Fluid 67 2.2.2 Methods 67 2.2.2.1 Original Radioimmunoassay Method for Serum 67 Solanidine 2.2.2.2 Modified Radioimmunoassay Method for Serum 69 Solanidine 2.2.2.3 Radioimmunoassay for Serum Total Alkaloid 71 71 2.2.2.4 Radioimmunoassay Method for Salivary Solanidine and Total Alkaloid 2.2.2.3 Radioimmunoassay Method for Urinary Solanidine 72 and Total Alkaloid 2.2.2.6 Summary of Potato Alkaloid Radioimmunoassay 72 2.2.2.7 Quality Control 78 2.3 Results 81 2.3.1 Development and Validation of the Radioimmunoassay 81 for Potato Alkaloids 2.3.1.1 Radioactive 8-Counting 81 2.3.1.2 Label 82 2.3.1.3 Antiserum 85 2.3.1.4 Establishment of Total Alkaloid Assay 96 2.3.1.5 Optimisation of Sample Volume 96 2.3.1.6 Preparation of the Standard Curve 101 2.3.1.7 Assay Incubation Times 104 2.3.1.8 Detection Limit 106 2.3.1.9 Precision 108 2.3.1.10 Label Immunoreactivity 108 2.3.1.11 Assay Recovery 108 2.3.1.12 Non-Specific Binding 113 2.3.1.13 Zero Binding 113 2.3.1.14 50% Intercept 113 Page SECTION 3 NEURAL TUBE DEFECTS 3.1 Introduction 114 3.2 Potato Alkaloids and Neural Tube Defects 124 3.2.1 Introduction 124 3.2.2 M aterials and Methods 128 3.2.2.1 Collection of Specimens 128 3.2.2.2 Analytical Methods 129 3.2.3 Results 129 3.2.4 Discussion 140 3.3 Zinc and Neural Tube Defects 146 3.3.1 Introduction 146 3.3.2 Materials and Methods 149 3.3.2.1 Collection of Specimens 149 3.3.2.2 Analytical Methods 149 3.3.3 Results 151 3.3.4 Discussion 158 3.4 Folate and Neural Tube Defects 161 3.4.1 Introduction 161 3.4.2 Analytical Method 161 3.4.3 Results 162 3.4.4 Discussion 163 SECTION 4 ALKALOID CONCENTRATIONS IN SELECTED POPULATIONS 4.1 Alkaloid Concentrations in the Normal Population 165 4.1.1 Introduction 165 4.1.2 Materials and Methods 165 4.1.2.1 Collection of Samples 165 4.1.2.2 Analytical Methods 166 4.1.3 Results 167 4.1.4 Discussion 167 4.2 Toxicological Effects of Excessive Intake of 178 Potato Glycoalkaloids in Man 4.2.1 Introduction 178 4.2.2 Materials and Methods 178 4.2.2.1 Case History 178 4.2.2.2 Glycoalkaloid Analysis 179 4.2.3 Results 179 4.2.4 Discussion 180 Page SECTION 5 POTATO ALKALOIDS IN HUMAN SALIVA 5 J Introduction 186 5.2 Materials and Methods 193 5.2.1 Collection of Specimens 193 5.2.2 Analytical Methods 193 5.3 Results 195 5.4 Discussion 204 SECTION 6 AFFINITY CHROMATOGRAPHY 6.1 Introduction 206 6.2 Materials and Methods 213 6.2.1 M aterials 213 6.2.2 Analytical Methods 214 6.2.2.1 Preparation of Anti-Solanum Alkaloid Immunosorbent 214 Using Cyanogen Bromide Activated Sepharose 4B 6.2.2.2 Preparation of Solanidine Free Serum, Urine and 216 Saliva 6.2.2.3 Preparation of Porous Glass and Controlled Pore 218 Ceramic Immunosorbents 6.2.2.4 A ffinity Extraction of Serum Samples and Removal 218 of Alkaloid Cross-Reactants 6.2.2.5 Scale Up of Controlled Pore Ceramic Column for 219 A ffinity Chromatography for 24 Hour Urine Samples 6.3 Results 221 6.4 Discussion 225 SECTION 7 HPLC AND TLC OF POTATO ALKALOIDS 7.1 Introduction 226 7.2 Materials and Methods 235 7.2.1 M aterials 235 7.2.2 Analytical Methods 235 7.2.2.1 Hydrolysis and TLC Separation of Potato Alkaloids 235 7.2.2.2 Spectral Analysis of Potato Alkaloids 237 7.2.2.3 HPLC of Potato Alkaloids 237 7.2.2.4 Development of HPLC Method 238 7.3 Results 243 7.3.1 Spectral Analysis 243 7.3.2 TLC of Potato Alkaloids in Serum and Urine 243 7.3.3 HPLC Analysis of Potato Alkaloids in Serum and Urine 243 7.4 Discussion 254 Page SECTION 8 PHARMACOKINETICS OF POTATO ALKALOIDS 8.1 Introduction 256 259 8.2 Materials and Methods 259 8.2.1 M aterials 25q 8.2.2 Methods 25q 8.2.2.1 Preparation of the Potato Meal 25g 8.2.2.2 Pharmacokinetic Studies 26o 8.2.2.3 Analysis of Total Glycoalkaloid Content of Potatoes 8.2.2.4 Analysis of Alkaloid Content of Serum and Urine 261 8.3 Results 262 8.3.1 Total Glycoalkaloid Content of Potato Samples 262 8.3.2 Analysis of Serum and Urine from Pharmacokinetic 262 Study 8.4 Discussion 278 SECTION 9 GENERAL DISCUSSION AND CONCLUSIONS 9.1 Methodology 281 9.2 Alkaloid Concentrations in Normal Populations 285 9.3 Neural Tube Defects 287 9.4 Further Studies 289 ACKNOWLEDGEMENTS 291 REFERENCES 292 APPENDIX 307 SUMMARY Radioimmunoassay methods were developed for the measurement of solanidine and total alkaloid in serum, urine and saliva. Solanidine and total alkaloid concentrations were measured in a group of normal pregnant women and a group of women pregnant with a foetus subsequently shown to be affected by a neural tube defect (NTD). Serum alkaloid concentrations were, contrary to expectations, lower in the NTD group, casting doubt on the theory suggesting a link between potato alkaloids and NTD serum zinc and folate concentrations were also measured in the two groups and no significant differences were noted. Solanidine and total alkaloid concentrations were measured in the serum, urine and saliva of healthy volunteers and reference ranges established. Total alkaloid concentrations were higher than solanidine in serum and urine but similar in saliva, indicating solanidine as the predominant salivary alkaloid. Alkaloid concentrations measured in a case of potato poisoning and in subjects on high alkaloid intake had serum, urine and salivary solanidine and total alkaloid concentrations much greater than the reference ranges. A pharmacokinetic study was carried out to obtain body fluid alkaloid concentrations following a potato load. The glycosides were found to be rapidly absorbed before metabolism to solanidine;urinary excretion accounted for a very small percentage of the to ta l dose. A ffinity chromatography allowed concentration of potato alkaloids in urine and serum for qualitative analysis of metabolites. A high performance liquid chromatography (HPLC) method was developed and used in conjunction with thin layer chromatography (TLC) to separate the principle alkaloids found in urine and serum. As well as the glycosides, a- solanine and a-chaconine, the presence of the aglycone solanidine was established. Additionally, several of the lower glycosides were found in serum and urine. ABBREVIATIONS AFP Alpha Fetoprotein ASB Anencephaly and Spina B ifida Cystica BSA Bovine Serum Albumin B/Bo Percentage counts bound in zero tube c.p.m.
Load more

Recommended publications
  • Acid-Catalysed Hydroaminations
    Acid-Catalysed Hydroaminations A thesis submitted to Cardiff University by Laura Henderson MChem (Hons.) In candidature of the degree of Doctor of Philosophy School of Chemistry Cardiff University UMI Number: U557419 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. Dissertation Publishing UMI U557419 Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Acknowledgments First of all I would like to thank Prof. David W. Knight, for all his support, great ideas and seemingly endless breadth of knowledge that made this project possible. Secondly, I would also like to thank Dr. Andrew C. Williams for all the support and advice he has given over the last three years. I am grateful to the many students whose have contributed towards this thesis; they were all a joy to work with. In particular, I want to thank Nena Christiansen, Jon Williams and Rhian Courtney for their work. I want to thank Dr Rob Jenkins, Robin Hicks and Dave Walker for all of their mass spec, and NMR support over the years. I also want to thank Dr John Brazier and Dr Jacky Yau for all the advice and help that they gave, and endless enthusiasm that they have shown.
    [Show full text]
  • Microgram Journal, Vol 3, Number 2
    MICROGRAM Laboratory Operations Division Office Of Science And Drug Abuse Prevention BUREAU OF NARCOTICS & DANGEROUS DRUGS / U.S. DEPARTMENT OF JUSTICE / WASHINGTION, D.C. 20537 Vol.III, No. 2 March-April, 1970 STP (4-Methyl-2,5-dimethoxyamphetamine) hydrochloride was found coating the inside of capsules sent to BNDDfrom Germany. The capsules were clear, hard gelatin, standard shape size No. o. Average weight was 114 milligrams. Each capsule had a white crystalline coating on inner surface of capsule body. Apparently a measu~ed amount of solution had been placedin the cap·sule body, after which it was rotated to spread the solution on the inner surface. The substance contained 8. 7 milli­ grams STP (DOM)HCl per ca·psule. · These were the first STP capsules of this type seen by our laboratory. A few years ago, capsules were ob­ tained in the U.S. similarly coated with LSD. STP (Free Base) on laboratory filter paper, also from Germany, was seen for the first time in our laboratory. The STP spots, containing approxi­ mately 8 miliigrams STP base each, were 5/8 to 3/4 inch in diameter. The paper was 1\ inches square. Phencyclidine (Free Base) was recently analyzed on parsley leaves. Called "Angel DUst, 11 the phencyclidine on two samples of leaves was 2.6% and 3.6%. Approximately thirty pounds of 94% pure powder was also analyzed. (For identification of phencyclidine base, see Microgram, II, 1, p.3 (Jan 1969). IMITATIONSof well-known drug products are examined frequently in our Special Testing and Research Laboratory. Many of these are well made preparations and closely resemble the imitated product.
    [Show full text]
  • Plants and Parts of Plants Used in Food Supplements: an Approach to Their
    370 ANN IST SUPER SANITÀ 2010 | VOL. 46, NO. 4: 370-388 DOI: 10.4415/ANN_10_04_05 ES I Plants and parts of plants used OLOG D in food supplements: an approach ETHO to their safety assessment M (a) (b) (b) (b) D Brunella Carratù , Elena Federici , Francesca R. Gallo , Andrea Geraci , N (a) (b) (b) (a) A Marco Guidotti , Giuseppina Multari , Giovanna Palazzino and Elisabetta Sanzini (a)Dipartimento di Sanità Pubblica Veterinaria e Sicurezza Alimentare; RCH (b) A Dipartimento del Farmaco, Istituto Superiore di Sanità, Rome, Italy ESE R Summary. In Italy most herbal products are sold as food supplements and are subject only to food law. A list of about 1200 plants authorised for use in food supplements has been compiled by the Italian Ministry of Health. In order to review and possibly improve the Ministry’s list an ad hoc working group of Istituto Superiore di Sanità was requested to provide a technical and scientific opinion on plant safety. The listed plants were evaluated on the basis of their use in food, therapeu- tic activity, human toxicity and in no-alimentary fields. Toxicity was also assessed and plant limita- tions to use in food supplements were defined. Key words: food supplements, botanicals, herbal products, safety assessment. Riassunto (Piante o parti di piante usate negli integratori alimentari: un approccio per la valutazione della loro sicurezza d’uso). In Italia i prodotti a base di piante utilizzati a scopo salutistico sono in- tegratori alimentari e pertanto devono essere commercializzati secondo le normative degli alimenti. Le piante che possono essere impiegate sono raccolte in una “lista di piante ammesse” stabilita dal Ministero della Salute.
    [Show full text]
  • Food and Health in Europe: Europe: in Health and Food WHO Regional Publications
    Food and health in Europe: Food and health WHO Regional Publications European Series, No. 96 a new basis for action Food and health in Europe: a new basis for action 96 The World Health Organization was established in 1948 as a specialized agency of the United Nations serving as the directing and coordinating authority for international health matters and public health. One of WHO’s constitutional functions is to provide objective and reliable information and advice in the field of human health, a responsibility that it fulfils in part through its publications programmes. Through its publications, the Organization seeks to support national health strategies and address the most pressing public health concerns. The WHO Regional Office for Europe is one of six regional offices throughout the world, each with its own programme geared to the particular health problems of the countries it serves. The European Region embraces some 870 million people living in an area stretching from Greenland in the north and the Mediterranean in the south to the Pacific shores of the Russian Federation. The European programme of WHO therefore concentrates both on the problems associated with industrial and post-industrial society and on those faced by the emerging democracies of central and eastern Europe and the former USSR. To ensure the widest possible availability of authoritative information and guidance on health matters, WHO secures broad international distribution of its publications and encourages their translation and adaptation. By helping to promote and protect health and prevent and control disease, WHO’s books contribute to achieving the Organization’s principal objective – the attainment by all people of the highest possible level of health.
    [Show full text]
  • Towards a Molecular Understanding of the Biosynthesis of Amaryllidaceae Alkaloids in Support of Their Expanding Medical Use
    Int. J. Mol. Sci. 2013, 14, 11713-11741; doi:10.3390/ijms140611713 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Towards a Molecular Understanding of the Biosynthesis of Amaryllidaceae Alkaloids in Support of Their Expanding Medical Use Adam M. Takos and Fred Rook * Plant Biochemistry Laboratory, Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, 1871 Frederiksberg, Denmark; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +45-3533-3343; Fax: +45-3533-3300. Received: 28 April 2013; in revised form: 26 May 2013 / Accepted: 27 May 2013 / Published: 31 May 2013 Abstract: The alkaloids characteristically produced by the subfamily Amaryllidoideae of the Amaryllidaceae, bulbous plant species that include well know genera such as Narcissus (daffodils) and Galanthus (snowdrops), are a source of new pharmaceutical compounds. Presently, only the Amaryllidaceae alkaloid galanthamine, an acetylcholinesterase inhibitor used to treat symptoms of Alzheimer’s disease, is produced commercially as a drug from cultivated plants. However, several Amaryllidaceae alkaloids have shown great promise as anti-cancer drugs, but their further clinical development is restricted by their limited commercial availability. Amaryllidaceae species have a long history of cultivation and breeding as ornamental bulbs, and phytochemical research has focussed on the diversity in alkaloid content and composition. In contrast to the available pharmacological and phytochemical data, ecological, physiological and molecular aspects of the Amaryllidaceae and their alkaloids are much less explored and the identity of the alkaloid biosynthetic genes is presently unknown. An improved molecular understanding of Amaryllidaceae alkaloid biosynthesis would greatly benefit the rational design of breeding programs to produce cultivars optimised for the production of pharmaceutical compounds and enable biotechnology based approaches.
    [Show full text]
  • Botanical Medicine
    prohealth QUICK REFERENCE EVIDENCE INFORMED BOTANICAL MEDICINE ,ĞƌďƐ͕ŶƵƚƌŝƟŽŶ͕ŚŽƌŵŽŶĞƐΘŵĞĚŝĐĂƟŽŶƐ ƌ͘DĂƌŝƐĂDĂƌĐŝĂŶŽΘƌ͘EŝŬŝƚĂ͘sŝnjŶŝĂŬ Introduction ............... 1 Botanical Studying Tips ................. iii Plant Harvesting ............................ vi Intro Intro Food is Medicine ........7 3URWHLQIDW¿EHUFDUERK\GUDWHV .... 9 A Vitamins & minerals .......................14 B Actions ....................... 31 C Constituents............... 59 D Pharmacy ................... 73 E Monographs A-Z.... ..... 85 F Appendix .................... 370 G Toxicology, CIs & Safe Dosing .............370 +HUEVLQ3UHJQDQF\ ............................. 376 H +HUEVLQ3HGLDWULFV .............................. 377 I 13/(; ERDUGH[DPKHUEOLVW ............ 378 +HUEVE\)DPLO\ ................................... 379 J +HUE'UXJ1XWULHQW,QWHUDFWLRQV .......... 382 K Medications (drug & use) .....................386 L Index .......................... 403 +HUEVE\ODWLQQDPH ............................. 406 M +HUEVE\FRPPRQQDPH ..................... 407 N Congratulations RQPDNLQJWKHEHVWLQYHVWPHQWRI\RXUOLIH\RXURZQHGXFDWLRQDQG\RXU O FRQWLQXHGVHUYLFHWR\RXUSDWLHQW¶VTXDOLW\RIOLIH7RKHOSVXSSRUW\RXWKLVWH[WZDVFUHDWHG P DVWKHPRVWXSWRGDWHIXQFWLRQDODQGFRVWHIIHFWLYHFOLQLFDOWH[WDYDLODEOH&RXQWOHVVKRXUVRI UHVHDUFK GHVLJQZHUHVSHQWWRGHYHORSWKHFRQWHQW IRUPDW,QIRUPDWLRQVRXUFHVLQFOXGH Q KXQGUHGVRIRULJLQDOSHHUUHYLHZHGUHVHDUFKDUWLFOHVZLWKFXWWLQJHGJHLQIRUPDWLRQ GHFDGHVRI R HYLGHQFHLQIRUPHGEHVWSUDFWLFHV PXOWLGLVFLSOLQDU\FOLQLFDOH[SHULHQFHZLWKDIRFXVRQresults S based medicine. ,QRUGHUWRJHWWKHPRVWFOLQLFDOXWLOLW\IURPWKLVWH[WLWPXVWEHDYDLODEOHDWDOOWLPHVDVVXFK
    [Show full text]
  • Alkaloids Volume 1
    A Specialist Periodical Report The Alkaloids Volume 1 A Review of the Literature Published between January 1969 and June 1970 Senior Reporter J . E. Saxton, Department of Organic Chemistry, The University of Leeds Reporters A. R. Battersby, Cambridge University K. W. Bentley, Reckitt and Sons Ltd., Hull 0. E. Edwards, National Research Council of Canada, Ottawa R. Goutarel, Centre Nationale de la Recherche Scientifique, Gif-sur- Yvette, France A. Gorman, Manchester University R. B. Herbert, University of Leeds M. Hesse, University of Zurich W. H. Hopff, University of Zurich J. A. Joule, Manchester University E. Schlittler, Heidelberg University H. Schmid, University of Zurich V. A. Snieckus, University of Waterloo, Canada E. W. Warnhoff, University of Western Ontario, Canada P. G. Waser, University of Zurich SBN: 85186 257 8 0 Copyright 1971 The Chemical Society Burlington House, London, WIV OBN Set in Times on Monophoto Filmsetter and printed offset by J. W. Arrowsmith Ltd., Bristol, England Made in Great Britain Foreword This volume is the first in the series of annual Specialist Periodical Reports devoted to the chemistry of the Alkaloids. In preparing this first volume our aim has been not simply to record progress during a selected period, but also to include whatever background material and earlier references are necessary to enable the new work to be placed in perspective in its own particular area; in consequence we hope that the reader, whether the alkaloid specialist or the general reader, will be able to read and benefit from the discussions presented here with the minimum of reference to the standard monographs on the subject.
    [Show full text]
  • Appendix: Drug Dosing in Renal Failure
    44. Drug dosage in renal failure Appendix: Drug dosing in renal failure Abbreviations used: ACE: angiotensin-converting enzyme AV: atrioventricular BUN: blood urea nitrogen CCr: Creatinine clearance CAPD: continuous ambulatory peritoneal dialysis CHF: congestive heart failure CMV: cytomegalovirus CNS: central nervous system CRRT: continuous renal replacement therapy CSA/FK: cyclosporine A and tacrolimus CVD: cardiovascular disease CVVH: Continuous venovenous hemofiltration DVT: deep vein thrombosis ESRD: end-stage renal disease GI: gastrointestinal GFR: glomerular filtration rate HBV: hepatitis B virus HD: hemodialysis HDL: high-density lipoprotein HIT: heparin-induced thrombocytopenia HSV: herpes simplex virus INR: international normalized ratio IV: intravenous MI: myocardial infarction MMF: mycophenolate mofetil NA: not applicable NC: No data: no change required NSAIDs: nonsteroidal anti-inflammatory drugs TB: tuberculosis TDM: therapeutic drug monitoring VD: volume of distribution VZV: varicella zoster virus. 919 920 Table 2 . Antibacterial agents % of drug Dosage adjustment for renal failure with GFR Method of dosage adjustment Drug Normal dosage excreted (ml/min): Comments renally >50 10−50 <10 HD CAPD CVVH Aminoglycosides Group toxicity: all agents in this group are nephrotoxic and ototoxic; ototoxicity is worse when the patient is hyperbilirubinemic; measure serum levels for efficacy and toxicity; peritoneal absorption increases with presence of inflammation. V increases with edema, obesity, and ascites D Streptomycin 7.5 mg/kg q. 12 hr 60% q. 24 hr q. 24−72 hr q. 72−96 hr May be less nephrotoxic than other Half normal 20−40 mg/L/ Dose for GFR (1.0 g q. 24 hr members of class dose after day 10−50 ml/min; for TB) dialysis measure levels Kanamycin 7.5 mg/kg q.
    [Show full text]
  • Supporting Information
    Supporting Information © Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2007 How Many Traditional Chinese Medicine Components Have Been Recognized by Modern Western Medicine? A Chemoinformatic Analysis and Implications for Finding Multicomponent Drugs De-Xin Kong, Xue-Juan Li, Guang-Yan Tang and Hong-Yu Zhang Table S1. Common agents in TCMD and CMC database. TCMD TCMD Name CMC number CMC Name number 8793 Serotonine MCMC00000036 SEROTONIN 3033 Dulcitol MCMC00000037 SORBITOL 7311 Noradrenaline MCMC00000052 NOREPINEPHRINE 3016 Dopamine MCMC00000060 DOPAMINE 9994 Tyramine MCMC00000062 TYRAMINE 4072 Glycine MCMC00000134 GLYCINE 4065 Glycerol MCMC00000141 GLYCERIN 813 L-Aspartic acid MCMC00000142 ASPARTIC ACID 380 Allyl isothiocyanate MCMC00000148 ALLYL ISOTHIOCYANATE 9078 Stearic acid MCMC00000151 STEARIC ACID 10032 Urea MCMC00000152 UREA 1237 Caffeine MCMC00000179 CAFFEINE 6687 2-Methyl-1,4-naphthoquinone MCMC00000187 MENADIONE 7615 Papaverine MCMC00000198 PAPAVERINE 7221 Nicotinic acid MCMC00000223 NIACIN 993 Benzyl ethyl alcohol MCMC00000229 PHENYLETHYL ALCOHOL 8204 Pyridoxine MCMC00000287 PYRIDOXINE 965 Benzoic acid MCMC00000292 BENZOIC ACID 7481 Orotic acid MCMC00000293 OROTIC ACID 2591 Dicoumarin MCMC00000296 DICUMAROL 10205 Vitamin A MCMC00000318 RETINOL 6026 D-Mannitol MCMC00000331 MANNITOL 8564 Salicylic acid MCMC00000332 SALICYLIC ACID 1693 Citric acid MCMC00000419 CITRIC ACID 10208 Vitamin B5 MCMC00000432 PANTOTHENIC ACID 5467 Khellin MCMC00000452 KHELLIN 9626 Theobromine MCMC00000463 THEOBROMINE 7843 Phytic acid MCMC00000465
    [Show full text]
  • Introduction (Pdf)
    Dictionary of Natural Products on CD-ROM This introduction screen gives access to (a) a general introduction to the scope and content of DNP on CD-ROM, followed by (b) an extensive review of the different types of natural product and the way in which they are organised and categorised in DNP. You may access the section of your choice by clicking on the appropriate line below, or you may scroll through the text forwards or backwards from any point. Introduction to the DNP database page 3 Data presentation and organisation 3 Derivatives and variants 3 Chemical names and synonyms 4 CAS Registry Numbers 6 Diagrams 7 Stereochemical conventions 7 Molecular formula and molecular weight 8 Source 9 Importance/use 9 Type of Compound 9 Physical Data 9 Hazard and toxicity information 10 Bibliographic References 11 Journal abbreviations 12 Entry under review 12 Description of Natural Product Structures 13 Aliphatic natural products 15 Semiochemicals 15 Lipids 22 Polyketides 29 Carbohydrates 35 Oxygen heterocycles 44 Simple aromatic natural products 45 Benzofuranoids 48 Benzopyranoids 49 1 Flavonoids page 51 Tannins 60 Lignans 64 Polycyclic aromatic natural products 68 Terpenoids 72 Monoterpenoids 73 Sesquiterpenoids 77 Diterpenoids 101 Sesterterpenoids 118 Triterpenoids 121 Tetraterpenoids 131 Miscellaneous terpenoids 133 Meroterpenoids 133 Steroids 135 The sterols 140 Aminoacids and peptides 148 Aminoacids 148 Peptides 150 β-Lactams 151 Glycopeptides 153 Alkaloids 154 Alkaloids derived from ornithine 154 Alkaloids derived from lysine 156 Alkaloids
    [Show full text]
  • NAST 1993 Annual Report
    NAST Annual Report 1993 ATIONAL ACADEMY OF SCIENCE AND TECHNOLOGY Republic of the Philippines ~993 NAST Annual Report 1993 NATIONAL ACADEMY OF SCIENCE AND TECHNOWGY TAPI Bldg.• DOST Compound Bicutan. Taguig. Metro Manila FOREWORD The National Academy of Science and Technology, the recognition and advisory body on science and technology, presents this annual report on the Academy's programs and activities for Calendar Year 1993. YRIT, M.D. President CONTENTS NAST Recognition Function New Academicians ................................................................................................ 1 1993 Outstanding Young Scientist (OYS) Awards ............................................. 1 1993 NAST-TWAS Science Prize (Physics) ....................................................... 8 1993 Awards for Outstanding Published Papers ................................................. 8 Benefits of Academicians .................................................................................... 13 Advisory Function ...................................................................................................... 16 15th Annual Scientific Meeting Guidelines on Ethics for Researchers ................................................................ 16 Advice ................................................................................................ - ................. 19 Botanical Garden ................................................................................................. 20 International Linkages .................................................................................
    [Show full text]
  • Organic Seminar Abstracts
    LIB RA R.Y OF THE UN 1VERSITY or 1 LLI NOIS Q.541 pt.l Return this book on or before the Latest Date stamped below. Theft, mutilation, and underlining of books are reasons for disciplinary action and may result in dismissal from the University. University of Illinois Library L161— O-1096 Digitized by the Internet Archive in 2012 with funding from University of Illinois Urbana-Champaign http://archive.org/details/organicsemi1962631univ ORGANIC SEMINAR ABSTRACTS I962-I963 IVERSITY OF ILLINOIS LIBRARY Paging varies but this is complete. Department of Chemistry and Chemical Engineering University of Illinois ORGANIC SEMIHAR ABSTRACTS 1962-1963 Semester I Department of Chemistry and Chemical Engineering University of Illinois SEMINAR TOPICS I Semester 1962-I963 Introduction of Functionality in the Angular Position of Fused Ring; Systems G. E. Wilson, Jr 1 Dinitrocyclohexanes Philip C. Kelley ......... 7 it -Complexes of Transition Metals with Mono-olefins M. P. Dixon 16 Structural Studies of Macrocyclic Pentaene Antibiotics G. Leadbeiter ...... Recent Applications of the Wittig Reaction H. E. Dunn . 33 Chemistry of Cyclic Azo Compounds T. II. Fisher ho The Mechanism of the Benzidine Rearrangement Richard A. Laursen . k-S) Conformational Studies of Five-membered Rings R. L. Buckson 58 Structure of Catalposide Walter J. Musliner 67 Recent Investigations on Morphine and Related Compounds Richard F, Schimbor 7^- The Biosynthesis of Branched Chain Fatty Acids W. P. O'Neill G3 The Photolysis of Diazoketones T. M. Warne 92 Nuclear Magnetic Double Resonance John P. Petrovich ........ 100 Stereochemistry, Synthesis and Biogenesis of Tropanes Richard K. Olsen 109 cis -trans Isomerization Mechanisms in Acid Solution L.
    [Show full text]